CAMERON SWEENEY: Open Payments
NPI 1073961744 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 8 payments from 5 companies in 2025. Trend: 2023 $236 · 2024 $0 · 2025 $473
Food & beverage: $374Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $281 |
| Gilead Sciences, Inc. | 2 | $117 |
| Astellas Pharma US Inc | 1 | $31 |
| Genentech USA, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
Products named: Trodelvy, Vyloy, ENHERTU, Tecentriq, VERZENIO.
Industry payments across NC — which companies pay providers there.
